Evidence map›Paper›PMID 22159873›Full record

ArticleMolecular & cellular proteomics : MCP2012

TraML--a standard format for exchange of selected reaction monitoring transition lists.

Eric W Deutsch, Matthew Chambers, Steffen Neumann, Fredrik Levander, Pierre-Alain Binz, Jim Shofstahl, David S Campbell, Luis Mendoza, David Ovelleiro, Kenny Helsens and 4 more

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Article
  3. Proteomics Standards Initiative Extended FASTA Format.Journal of proteome research · 2019
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Eric W DeutschInstitute for Systems Biology, Seattle, Washington 98109, USA. edeutsch@systemsbiology.org
Matthew Chambers
Steffen Neumann
Fredrik Levander
Pierre-Alain Binz
Jim Shofstahl
David S Campbell
Luis Mendoza
David Ovelleiro
Kenny Helsens
Lennart Martens
Ruedi Aebersold
Robert L Moritz
Mi-Youn Brusniak

Funding

Quantitative Systems BiologyP50GM076547 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI AITCHISON, JOHN D. · 2006 to 2016
$30.6M
Shortening the development cycle time of Trans Proteomic Pipeline tools with high performance computingR01GM087221 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI DEUTSCH, ERIC, MORITZ, ROBERT L · 2010 to 2021
$6.0M
Complete Human Peptide- and MRM-AtlasRC2HG005805 · NHGRI · INSTITUTE FOR SYSTEMS BIOLOGY · PI HOOD, LEROY E, MORITZ, ROBERT L · 2009 to 2010
$4.6M
NHLBI PROTEOMICS INITIATIVE-268028179N01HV028179 · HV · INSTITUTE FOR SYSTEMS BIOLOGY · 2002 to 2002
–
NHGRI NIH HHS HG005805NHGRI NIH HHS RC2 HG005805NHLBI NIH HHS N01 HV028179NHLBI NIH HHS N01-HV-28179NIGMS NIH HHS GM087221NIGMS NIH HHS P50 GM076547NIGMS NIH HHS R01 GM087221
6 · The paper itself

Abstract

Targeted proteomics via selected reaction monitoring is a powerful mass spectrometric technique affording higher dynamic range, increased specificity and lower limits of detection than other shotgun mass spectrometry methods when applied to proteome analyses. However, it involves selective measurement of predetermined analytes, which requires more preparation in the form of selecting appropriate signatures for the proteins and peptides that are to be targeted. There is a growing number of software programs and resources for selecting optimal transitions and the instrument settings used for the detection and quantification of the targeted peptides, but the exchange of this information is hindered by a lack of a standard format. We have developed a new standardized format, called TraML, for encoding transition lists and associated metadata. In addition to introducing the TraML format, we demonstrate several implementations across the community, and provide semantic validators, extensive documentation, and multiple example instances to demonstrate correctly written documents. Widespread use of TraML will facilitate the exchange of transitions, reduce time spent handling incompatible list formats, increase the reusability of previously optimized transitions, and thus accelerate the widespread adoption of targeted proteomics via selected reaction monitoring.

Indexed as

Information SystemsProteomicsSoftware

Identifiers

PMID22159873
PMCPMC3322582

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.